Related Links:
For additional information regarding the ROX Solution, please refer to the following links.
- Venous Admixture in COPD: COPD: Journal of COPD
- Percutaneous Creation of...: Vascular Disease Management
- An Arteriovenous Fistula Increase Exercise Capacity in Patients with COPD: CHEST
ROX Medical has developed the ROX Anastomotic Coupling Procedure for use in the treatment of advanced Chronic Obstructive Pulmonary Disease (COPD). A therapeutic fistula in the ilio-femoral region allows blood rich in oxygen to flow from the artery to the vein, thereby increasing the oxygen content of blood returning to the lungs. The result may increase perfusion through the pulmonary system and may improve oxygen delivery to tissue. Overall changes in physiology benefits to COPD patients may include increases in cardiac output, increased oxygenation of blood that is returning to the heart (thereby reducing hypoxemia), as well as a potential reduction of pulmonary vascular resistance. Thus, creation of a therapeutic arteriovenous fistula aims to utilize reserves in the cardiovascular system to compensate for deficiencies in respiratory function.
If you, or someone you know, suffers from acute COPD complications and would like to learn more about our ongoing clinical trials, please click here.
To learn more about living with severe Chronic Obstructive Pulmonary Disease (COPD), visit our COPD FAQ’s page.
